China Vaccine Market Report, 2007-2009
China is the largest vaccine producer and consumer in the
world. According to the statistics of the General Administration
of Customs, China's total vaccine import and export volume
reached 34,846 tons in the first five months of 2008, of which
7,735 tons were imports, and 27,111 tons were exports.
China's total vaccine import and export value in the same
period was US$217.52 million, of which US$197.73 million was
import value, and US$19.79 million was export value.
In 2007, China's total vaccine import and export volume
reached 2,320 tons, of which 1,500 tons were imports, 820
tons were exports. China's total vaccine import and export
value hit US$386.79 million, of which US$344.28 million was
import value, and US$42.51 million was export value.
China Vaccine Import and Export, 2007
(unit: US$ million)
Source: China Customs; ResearchInChina
Based on the authoritative statistics of the National Bureau of Statistics, the State-Owned Assets Supervision and
Administration Commission, the State Information Center, the Development Research Center of the State Council,
the China Pharmaceutical Association, and the General Administration of Customs, this report makes in-depth
analysis on China bio-pharmaceutical industry development, vaccine market, impact of SARS on vaccine market,
vaccine import & export, key vaccine markets, key vaccine producers, investment opportunities and also makes
forecast on the development trend of China's vaccine industry.
•
1. China Vaccine Market in Globalization Process
•
2.5 Market Development Trend, 2008
•
1.1 Impact of Globalization on China Pharmaceutical
Market
•
2.6 Suggestions for Vaccine Industry Development,
2008
•
1.1.1 Pharmaceutical Industry Restructuring and
International Division of Labor
•
3. Market of Main Varieties of Vaccine, 2008
•
3.1 China Flu Vaccine Market, 2008
•
3.1.1 Market Background
•
3.1.2 Research and Development
•
1.1.2 Accelerated Globalization Process of
Pharmaceutical Market
•
1.1.3 International Status of China Pharmaceutical
Industry
•
1.1.4 Forecast of China Status in Global
Pharmaceutical Industry, 2009
•
3.1.3 Market Size
•
3.1.4 Competition
•
1.2.1 China Vaccine Market
•
3.1.5 Market Demand
•
1.2.2 Policy on Foreign Capital Entry into China
Vaccine Market
•
3.1.6 Key Producers
•
1.2.3 Competition Strategies of Chinese Vaccine
Companies
•
3.2 China HBV Vaccine Market
•
3.2.1 Market Background
•
1.3 China Vaccine Market Position in the Global
Market
•
3.2.2 Market Size
•
3.2.3 Main Products
•
3.2.3.1 Plasma Derived HB Vaccine
•
2. China Vaccine Market Development in 2008-2009 •
•
2.1 Market Characteristics, 2008
•
2.2 Main Vaccines Types, 2008
•
2.3 Market Structure, 2008
•
2.4 Market Characteristics, 2008
•
3.2.3.2 Recombinant HB Vaccine
3.2.3.3 Recombinant Vaccine of HB Virus Surface
Antigens CHO cell
•
3.2.3.4 New Type of HBV
•
3.2..4 Market Price
•
3.2.5 Key Producers
•
3.6.1.4 DNA Vaccine
•
3.3 China Epidemic Cerebrospinal Meningitis
Vaccine Market
•
3.6.1.5 Dendritic Cell Vaccine
•
3.3.1 Market Background
•
3.6.1.6 Peptide Vaccine
•
3.3.2 Market Size
•
3.6.2 China Measles Vaccine Market
•
3.3.2 Key Producers
•
3.6.3 China Research on Cervical Cancer Vaccine
•
3.4 China AIDS Vaccine Market
•
3.6.4 China Research on Lupus Erythematosus
Vaccine
•
3.4.1 Market Background
•
3.6.5 China Research on Rotavirus Vaccine
•
3.4.2 Market Size
•
3.6.6 Principle of Tumor Vaccine
•
3.4.3 Research and Development
•
3.7 China Animal Vaccine Market
•
3.4.3.1 China Research on AIDS Vaccine
•
3.7.1 Development Advantages
•
3.4.3.2 Research Direction
•
3.7.1.1 Basis of Demand
•
3.4.3.5 Process of Research Projects
•
•
3.5 China Bird Flu Vaccine Market
3.7.1.2 Green Barriers: Promotion of Animal
Vaccine
•
3.5.1. Market Background
•
•
3.5.2 Research and Development
3.7.1.3 Market Background of and Demand for Pet
Vaccine
•
3.5.3 Key Producers
•
3.7.1.4 Key Producers
•
3.6 Other Vaccine Market and Research and
Development
•
3.7.2 Research Progress in Vaccine for Animal
Use
•
3.6.1 Lung Cancer Vaccine
•
3.7.2.1 Research and Development of Animal
Virus Vaccine
•
3.6.1.1 Tumor Cell Vaccine
•
3.7.2.2 R&D Bases of China Animal Vaccine
•
3.6.1.2 Anti Tumor Antigen Vaccine
•
•
3.6.1.3 Anti-idiotypic Vaccine
3.7.2.3 Successful Development of Purified Rabies
Vaccine for Human Use
•
3.7.2.4 Research Progress in Pseudorabies Genedeleted Vaccine
•
6.1.1.2 Operation Status
•
6.1.2 Beijing Tiantan Biological Products Co., Ltd.
•
6.1.2.1 Company Profile
•
4. Impact of SARS on Vaccine Market
•
6.1.2.2 Operation Status
•
4.1 Vaccine Market Activated by SARS
•
6.1.3 Shanghai Institute of Biological Products
•
4.1.1 Booming of Vaccine Industry
•
•
4.1.2 Bottleneck of Vaccine Industry
6.1.4 Shenzhen Kangtai Biological Products Co.,
Ltd
•
4.1.3 Research and Development of SARS
Vaccine
•
6.1.5 Changchun Changsheng Life Sciences Co.,
Ltd
•
4.2 Dispute of SARS Patent and Market
•
6.1.6 Shenzhen Neptunus Bioengineering Co., Ltd
•
4.3 Patent Protection Measures on Anti SARS
Vaccine
•
6.1.6.1 Company Profile
•
6.1.6.2 Operation Status
•
6.1.7 Guangxi Beisheng Pharmaceutical Co., Ltd.
•
5. Import and Export of China Vaccine
•
6.1.7.1 Company Profile
•
5.1 General Trend of Vaccine Trade
•
6.1.7.2 Operation Status
•
5.3 Vaccine Export Regions Structure
•
6.1.8 Star Lake Bioscience Co., Ltd
•
5.4 Trade Methods Structure of Vaccine
•
6.1.8.1 Company Profile
•
5.5 Comparison between Imported Vaccine and
Homemade Vaccine
•
6.1.8.2 Operation Status
•
6.1.9 Shanghai Fosun Pharmaceutical (Group)
Co., Ltd
•
6. China Key Vaccine Producers
•
6.1.9.1 Company Profile
•
6.1 Main Vaccine Companies
•
6.1.9.2 Operation Status
•
6.1.1 China National Biotech Group Co., Ltd
•
6.1.1.1 Company Profile
•
7. Vaccine Market Development Trend and
Forecast, 2009
•
7.1 Latest Information on Vaccine Research and
Development
•
8. Operation Status of Biopharmaceutical
Industry
•
7.1.1 Development Trend of New Type of Vaccine
•
8.1 Operation Status, 2007
•
7.1.2 New Types of Vaccines
•
8.1.1 Output Value and Its Changes, 2007
•
7.1.2.1 Sub-unit Vaccine
•
8.1.2 Sales Revenue and Its Changes, 2007
•
7.1.2.2 Gene Recombination Vaccine
•
8.1.3 Total Output Value and Its Changes, 2007
•
7.1.2.3 Synthetic Vaccine
•
•
7.1.2.4 Immunoglobulin Carrier Vaccine
8.1.4 Changes in the Number of Key Producers,
2007
•
7.1.3 Research and Development of New Type of
Vaccine
•
8.1.5 Profit and Its Changes, 2007
•
•
7.1.3.1 Vaccine for Prevention of Respiratory
Disease
8.2 Business Operation of Top Ten Companies,
2007
•
•
7.1.3.2 Vaccine for Prevention of Digestive Disease
8.2.1 Changes in Sales Revenue of Top Ten
Companies, 2007
•
7.1.3.3 Vaccine for Prevention of Arbo Infectious
Disease
•
8.2.2 Changes in Assets of Top Ten Companies,
2007
•
7.1.4 New Type of Combined Vaccine
•
•
7.1.4.1 Development History
8.2.3 Changes in Profit of Top Ten Companies,
2007
•
7.1.4.2 Applications and Problems of Combined
Vaccine
•
8.2.4 Changes in Employees of Top Ten
Companies, 2007
•
7.1.4.3 Development of Combined Vaccine
•
7.1.4.4 Taking Oral Combined Vaccine
•
7.1.4.5 Immunity of Measles
•
7.1.4.6 Immunity of Mumps
•
7.1.4.7 Application of Varicella Vaccine
•
7.2 Forecast of Varicella Vaccine Market, 2009
•
Flu Vaccine Proportion in Main Vaccine Market
•
Flu Vaccine Producers Overseas
•
Flu Vaccine Producer at Home
•
China Key Vaccine Producers and Products
•
Virus Vaccine-Split Influenza Virus Vaccine's Dosage Form, Price & Origin, 2008
•
HB Vaccine Proportion in Main Vaccine Market
•
Virus Vaccine-Recombinant Vaccine of HB's (CHO cell Dosage Form, Price &
Origin, 2008
•
Virus Vaccine-Recombinant Vaccine of HB's (Barm) Dosage Form, Price & Origin,
2008
•
Main HB Vaccine Producers
•
Morbidity & Mortality of 27 kinds of Infectious Diseases Reported Statutorily
•
Main Regions of Epidemic Cerebrospinal Meningitis
•
Total Volume of Epidemic Cerebrospinal Meningitis Vaccine Put into Anhui
Province and Jiangsu Province
•
Statistics of China HIV-infected Patients
•
Informed Rate of China HIV-infected Patients
•
Forecast of China Future AIDS Vaccine Market
•
Profit Margin of Bird Flue Vaccine
•
Comparison of Import Value between Anti-serum and Vaccine in 2007-2008
Comparison of Import Volume between Anti-serum and in 2007-2008
•
Anti-serum and Vaccine Export Value, 2007-2008
•
Anti-serum and Vaccine Export Volume, 2007-2008
•
Profitability of Beijing Tiantan Biological Products Co., 2007-2008
•
Operation Ability of Beijing Tiantan Biological Products Co., 2007-2008
•
Debt-paying Ability of Beijing Tiantan Biological Products Co., 2007-2008
•
Capital Structure of Beijing Tiantan Biological Products Co., 2007-2008
•
Development Ability of Beijing Tiantan Biological Products Co., 2007-2008
•
Cash Flow of Beijing Tiantan Biological Products Co., 2007-2008
•
Profitability of Shenzhen Neptunus Bioengineering Co., 2007-2008
•
Operation Ability of Shenzhen Neptunus Bioengineering Co.,2007-2008
•
Debt-paying Ability of Shenzhen Neptunus Bioengineering Co., 2007-2008
•
Cash Flow of Beijing Shenzhen Neptunus Bioengineering Co., 2007-2008
•
Profitability of Guangxi Beisheng Pharmaceutical Co.,2007-2008
•
Operation Ability of Guangxi Beisheng Pharmaceutical Co., 2007-2008
•
Debt-paying Ability of Guangxi Beisheng Pharmaceutical Co., 2007-2008
•
Capital Structure of Guangxi Beisheng Pharmaceutical Co.,2007-2008
•
Development Ability of Guangxi Beisheng Pharmaceutical Co., 2007-2008
•
Cash Flow of Beijing Guangxi Beisheng Pharmaceutical Co., 2007-2008
•
Profitability of Star Lake Bioscience Co., 2007-2008
•
Operation Ability of Star Lake Bioscience Co., 2007-2008
•
China Top 10 Pharmaceutical Giants, 2007
•
Hepatitis Vaccine Market Size Forecast, 2009
•
Vaccine for Children Market Forecast, 2009
•
Vaccine for Adults and Flu Vaccine Market Forecast,2009
•
Therapeutic Vaccine Market Size Forecast, 2009
Product details
How to Order
USD
File
Single user
2,000
PDF
Enterprisewide
3,000
PDF
Publication date: July 2008
By email:
report@researchinchina.com
By fax:
86-10-82600829
By online:
www.researchinchina.com
For more information, call our office in Beijing, China:
Tel: 86-10-82600828
Website: www.researchinchina.com